Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

APOC1 Protein

This Native APOC1 protein is produced in Human.
Catalog No. ABIN934463

Quick Overview for APOC1 Protein (ABIN934463)

Target

See all APOC1 Proteins
APOC1 (Apolipoprotein C-I (APOC1))

Protein Type

Native

Origin

  • 7
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Human

Source

  • 15
  • 3
  • 1
  • 1
Human

Purity

> 95 % pure
  • Characteristics

    Purified native Human ApoC-I protein
    Protein Source: Human plasma
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    Lyophilized from 10 mM NH0 CO3, pH 7.4.

    Precaution of Use

    Donor samples were tested and found to be negative for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2. Nonetheless caution should be used when handling this material as there is a margin of error in all tests.

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    -20 °C

    Storage Comment

    Aliquot and store at -20 °C.
  • Target

    APOC1 (Apolipoprotein C-I (APOC1))

    Alternative Name

    ApoC-I

    Background

    Apolipoprotein CI is one of the protein components of VLDL lipoprotein. The normal plasma concentration of Apo CI is 4-7 mg per 100 ml. Elevated levels of Apo CI may offer some protection from obesity and insulin-dependent diabetes. Some evidence exists that the Apo CI H2 gene is positively associated with late-onset Alzheimer's disease.
    Description: Human plasma.
    Alternative Names: Apo CI protein, ApoC1 protein, ApoC I protein, Apolipoprotein C-I protein

    Molecular Weight

    6.6 kDa

    Pathways

    Apoptosis
You are here:
Chat with us!